M. Aşık, E. Binnetoğlu, H. Şen, F. Gunes, A. Muratlı, D. Kankaya, F. Uysal, M. Şahin, K. Ukinç
{"title":"原发性甲状腺鳞状细胞癌合并淋巴细胞性甲状腺炎患者侵袭性较低的疾病","authors":"M. Aşık, E. Binnetoğlu, H. Şen, F. Gunes, A. Muratlı, D. Kankaya, F. Uysal, M. Şahin, K. Ukinç","doi":"10.5114/wo.2015.53372","DOIUrl":null,"url":null,"abstract":"Aim of the study Primary squamous cell carcinoma (SCC) of the thyroid gland is extremely rare. Infrequently, primary SCC of the thyroid gland is accompanied by other thyroid diseases such as Hashimoto's thyroiditis (HT). Recently, studies have demonstrated that differentiated thyroid cancer with coexisting HT has a better prognosis. However, the prognosis of patients with primary SCC of the thyroid gland and coexistent HT has not been clearly identified. We compared the clinical characteristics and disease stages of patients with primary SCC with and without lymphocytic thyroiditis (LT). Material and methods We reviewed reports of primary SCC of the thyroid gland published in the English literature. Results and conclusions We identified 46 papers that included 17 cases of primary SCC of the thyroid gland with LT and 77 cases of primary SCC of the thyroid gland without LT. Lymph node metastasis and local invasion rates did not differ between these two groups. Distant metastases were absent in patients with LT, and were observed in 13 (16.9%) patients without LT. A greater proportion of patients without LT had advanced stage disease (stage IV A-B-C) than patients with LT (p < 0.05). Patients with primary SCC of the thyroid gland and coexisting LT had lower tumour-node-metastasis stage and frequency of distant metastasis than those without LT. Lymphocytic infiltration in patients with SCC appears to limit tumour growth and distant metastases.","PeriodicalId":10652,"journal":{"name":"Contemporary Oncology","volume":"34 19","pages":"458 - 461"},"PeriodicalIF":0.0000,"publicationDate":"2015-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":"{\"title\":\"Less aggressive disease in patients with primary squamous cell carcinomas of the thyroid gland and coexisting lymphocytic thyroiditis\",\"authors\":\"M. Aşık, E. Binnetoğlu, H. Şen, F. Gunes, A. Muratlı, D. Kankaya, F. Uysal, M. Şahin, K. Ukinç\",\"doi\":\"10.5114/wo.2015.53372\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aim of the study Primary squamous cell carcinoma (SCC) of the thyroid gland is extremely rare. Infrequently, primary SCC of the thyroid gland is accompanied by other thyroid diseases such as Hashimoto's thyroiditis (HT). Recently, studies have demonstrated that differentiated thyroid cancer with coexisting HT has a better prognosis. However, the prognosis of patients with primary SCC of the thyroid gland and coexistent HT has not been clearly identified. We compared the clinical characteristics and disease stages of patients with primary SCC with and without lymphocytic thyroiditis (LT). Material and methods We reviewed reports of primary SCC of the thyroid gland published in the English literature. Results and conclusions We identified 46 papers that included 17 cases of primary SCC of the thyroid gland with LT and 77 cases of primary SCC of the thyroid gland without LT. Lymph node metastasis and local invasion rates did not differ between these two groups. Distant metastases were absent in patients with LT, and were observed in 13 (16.9%) patients without LT. A greater proportion of patients without LT had advanced stage disease (stage IV A-B-C) than patients with LT (p < 0.05). Patients with primary SCC of the thyroid gland and coexisting LT had lower tumour-node-metastasis stage and frequency of distant metastasis than those without LT. Lymphocytic infiltration in patients with SCC appears to limit tumour growth and distant metastases.\",\"PeriodicalId\":10652,\"journal\":{\"name\":\"Contemporary Oncology\",\"volume\":\"34 19\",\"pages\":\"458 - 461\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-08-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Contemporary Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5114/wo.2015.53372\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/wo.2015.53372","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
摘要
研究目的原发性甲状腺鳞状细胞癌(SCC)极为罕见。原发性甲状腺鳞状细胞癌罕见地伴有其他甲状腺疾病,如桥本甲状腺炎(HT)。近年来研究表明分化型甲状腺癌合并HT预后较好。然而,原发性甲状腺鳞状细胞癌合并HT患者的预后尚未明确。我们比较了原发性鳞状细胞癌伴和不伴淋巴细胞性甲状腺炎(LT)患者的临床特征和疾病分期。材料和方法我们回顾了英文文献中关于原发性甲状腺鳞状细胞癌的报道。结果和结论我们纳入了46篇论文,其中包括17例原发性甲状腺鳞状细胞癌合并LT和77例原发性甲状腺鳞状细胞癌不合并LT。两组之间淋巴结转移和局部侵袭率没有差异。在LT患者中没有远处转移,在13例(16.9%)无LT患者中观察到远处转移。无LT患者的晚期疾病(IV期A- b - c)比例高于LT患者(p < 0.05)。原发性甲状腺鳞状细胞癌合并淋巴细胞转移的患者比无淋巴细胞癌的患者有更低的肿瘤淋巴结转移分期和远处转移的频率。淋巴细胞浸润似乎限制了鳞状细胞癌的肿瘤生长和远处转移。
Less aggressive disease in patients with primary squamous cell carcinomas of the thyroid gland and coexisting lymphocytic thyroiditis
Aim of the study Primary squamous cell carcinoma (SCC) of the thyroid gland is extremely rare. Infrequently, primary SCC of the thyroid gland is accompanied by other thyroid diseases such as Hashimoto's thyroiditis (HT). Recently, studies have demonstrated that differentiated thyroid cancer with coexisting HT has a better prognosis. However, the prognosis of patients with primary SCC of the thyroid gland and coexistent HT has not been clearly identified. We compared the clinical characteristics and disease stages of patients with primary SCC with and without lymphocytic thyroiditis (LT). Material and methods We reviewed reports of primary SCC of the thyroid gland published in the English literature. Results and conclusions We identified 46 papers that included 17 cases of primary SCC of the thyroid gland with LT and 77 cases of primary SCC of the thyroid gland without LT. Lymph node metastasis and local invasion rates did not differ between these two groups. Distant metastases were absent in patients with LT, and were observed in 13 (16.9%) patients without LT. A greater proportion of patients without LT had advanced stage disease (stage IV A-B-C) than patients with LT (p < 0.05). Patients with primary SCC of the thyroid gland and coexisting LT had lower tumour-node-metastasis stage and frequency of distant metastasis than those without LT. Lymphocytic infiltration in patients with SCC appears to limit tumour growth and distant metastases.